Personalis Inc Equity-NMS: PSNL

$5.86 0.33 (June 12, 2025)

Healthcare

Diagnostics & Research

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$5.53
Open :$5.6
Today's high :$6.07
Today's low :$5.5
52W low :$1.135
52W high :$7.2
EPS(TTM): :-1.32
Shares O/S :88.33 M
Market cap :517.59 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Personalis Inc $5.86 +0.01% - 517.59M

Frequently Asked Questions

What is the share price of Personalis Inc today?

Personalis Inc (PSNL) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Personalis Inc

Personalis, Inc. is engaged in developing, marketing and selling advanced cancer genomic tests and analytics. The Company’s advanced genomic sequencing and analytics support the development of personalized cancer vaccines and other cancer immunotherapies. Its products include NeXT Personal, ImmunoI DNeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). NeXT Personal is a tumor-informed liquid biopsy test for the detection of minimal residual disease (MRD) and recurrence in cancer. NeXT Dx is a comprehensive tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. The Company performed WGS on human samples for research projects, such as population sequencing initiatives. The Company’s tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and the development of personalized cancer therapies.